Literature DB >> 2373114

Effects of cornstarch treatment in very young children with type I glycogen storage disease.

M Hayde1, K Widhalm.   

Abstract

Three children aged 1-2 years with glycogenosis type I were treated with 2 g/kg bodyweight oral cornstarch per meal (4-5 times a day) for a period up to 16 months. In comparison to the previous dietary regimen (day and nocturnal feedings every 3 h) the cornstarch diet stabilised serum glucose profiles and dramatically improved secondary hyperlipoproteinaemia. Mean total triglycerides decreased up to one half, consistent with a fall of very low density lipoprotein-triglycerides up to two thirds. Metabolic acidosis and hyperuricaemia did not occur and normal growth rates (0.7-1 cm/month) were achieved. We conclude that the cornstarch regimen even in the age group up to 2 years can be considered as an efficient alternative in the treatment of glycogenosis type I patients with less frequent feedings and without nocturnal infusion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373114     DOI: 10.1007/bf02034750

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

1.  Nocturnal intragastric infusion of glucose in management of defective gluconeogenesis with hypoglycemia.

Authors:  R M Ehrlich; B H Robinson; M H Freedman; N J Howard
Journal:  Am J Dis Child       Date:  1978-03

2.  The role of raw starches in the treatment of type I glycogenosis.

Authors:  J B Sidbury; Y T Chen; C R Roe
Journal:  Arch Intern Med       Date:  1986-02

3.  Glycogen storage disease type I.

Authors:  A Schiffrin; C Polychronakos; H Abu-Srair
Journal:  N Engl J Med       Date:  1986-08-21       Impact factor: 91.245

4.  Type I glycogen storage disease: five years of management with nocturnal intragastric feeding.

Authors:  H L Greene; A E Slonim; I M Burr; J R Moran
Journal:  J Pediatr       Date:  1980-03       Impact factor: 4.406

5.  Comparison of the effects of total parenteral nutrition, continuous intragastric feeding, and portacaval shunt on a patient with type I glycogen storage disease.

Authors:  I M Burr; J A O'Neill; D T Karzon; L J Howard; H L Greene
Journal:  J Pediatr       Date:  1974-12       Impact factor: 4.406

6.  The activity of hepatic lipase and lipoprotein lipase in glycogen storage disease: evidence for a circulating inhibitor of postheparin lipolytic activity.

Authors:  D P Muller; T R Gamlen
Journal:  Pediatr Res       Date:  1984-09       Impact factor: 3.756

7.  The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate.

Authors:  G P Smit; R Berger; R Potasnick; S W Moses; J Fernandes
Journal:  Pediatr Res       Date:  1984-09       Impact factor: 3.756

8.  Infant dumping syndrome: reversal of symptoms by feeding uncooked starch.

Authors:  R Gitzelmann; J Hirsig
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

9.  Development of functional responses in human exocrine pancreas.

Authors:  E Lebenthal; P C Lee
Journal:  Pediatrics       Date:  1980-10       Impact factor: 7.124

View more
  3 in total

1.  Nutritional deficiencies in a patient with glycogen storage disease type Ib.

Authors:  P S Kishnani; A Boney; Y T Chen
Journal:  J Inherit Metab Dis       Date:  1999-10       Impact factor: 4.982

Review 2.  Dietary management in glycogen storage disease type III: what is the evidence?

Authors:  Terry G J Derks; G Peter A Smit
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982

Review 3.  Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions.

Authors:  Terry G J Derks; Margreet van Rijn
Journal:  J Inherit Metab Dis       Date:  2015-01-30       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.